Nymox Pharmaceutical Corporation

NYMX | $0.2 -19.68% -23.88% 930K

(0.0% 1d) (0.0% 1m) (-56.5% 1y) (0.0% 2d) (-19.7% 3d) (0.0% 7d) (117.41% volume)
Earnings Calendar:
Market Cap: $ 18,103,028
http://www.nymox.com
Sec Filling | Patents | 4 employees

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

cancer prostate cancer msa treatment 3d

add to watch list Paper trade email alert is off

Press-releases

Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
Published: 2024-03-27 (Crawled : 13:30) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
awards

Nymox December 27 Message to Shareholders
Published: 2023-12-27 (Crawled : 15:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist

$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
Published: 2023-11-21 (Crawled : 17:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
california

Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
Published: 2023-11-09 (Crawled : 15:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
corporation

NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
Published: 2023-11-03 (Crawled : 18:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
order today

NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
Published: 2023-11-03 (Crawled : 14:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
california company order

IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
Published: 2023-11-02 (Crawled : 14:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
meeting

IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
Published: 2023-10-31 (Crawled : 14:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
meeting

Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
Published: 2023-10-27 (Crawled : 20:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
meeting

Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
Published: 2023-10-26 (Crawled : 14:00) - globenewswire.com
NYMX | $0.2 -19.68% -23.88% 930K

Health Technology

| Email alert Add to watchlist
review application

See all